G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth

Blood. 2006 Mar 1;107(5):1847-56. doi: 10.1182/blood-2005-04-1612. Epub 2005 Nov 10.

Abstract

Granulocyte colony-stimulating factor (G-CSF) drives the production, survival, differentiation, and inflammatory functions of granulocytes. Reactive oxygen species (ROSs) provide a major thrust of the inflammatory response, though excessive ROSs may be deleterious. G-CSF stimulation showed a time- and dose-dependent increase in ROS production, correlating with activation of Lyn and Akt. Inhibition of Lyn, PI3-kinase, and Akt abrogated G-CSF-induced ROS production. This was also blocked by DPI, a specific inhibitor of NADPH oxidase. Following G-CSF stimulation, neutrophils from Lyn-/- mice produced less ROSs than wild-type littermates. G-CSF induced both serine phosphorylation and membrane translocation of p47phox, a subunit of NADPH oxidase. Because patients with a truncated G-CSF receptor have a high risk of developing acute myeloid leukemia (AML), we hypothesized that dysregulation of ROSs contributes to leukemogenesis. Cells expressing the truncated G-CSF receptor produced more ROSs than those with the full-length receptor. G-CSF-induced ROS production was enhanced in bone marrow-derived neutrophils expressing G-CSFRdelta715, a truncated receptor. The antioxidant N-acetyl-L-cysteine diminished G-CSF-induced ROS production and cell proliferation by inhibiting Akt activation. These data suggest that the G-CSF-induced Lyn-PI3K-Akt pathway drives ROS production. One beneficial effect of therapeutic targeting of Lyn-PI3K-kinase-Akt cascade is abrogating ROS production.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Animals
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / enzymology
  • Cell Line
  • Cell Proliferation
  • Dose-Response Relationship, Drug
  • Drug Design
  • Enzyme Inhibitors / therapeutic use
  • Granulocyte Colony-Stimulating Factor / deficiency
  • Granulocyte Colony-Stimulating Factor / metabolism
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / metabolism
  • Mice
  • Mice, Knockout
  • NADPH Oxidases
  • Neutrophils / cytology
  • Neutrophils / enzymology*
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphoproteins / metabolism
  • Protein Transport / drug effects
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Reactive Oxygen Species / metabolism*
  • Receptors, Granulocyte Colony-Stimulating Factor / genetics
  • Receptors, Granulocyte Colony-Stimulating Factor / metabolism
  • Sequence Deletion / genetics
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • src-Family Kinases / antagonists & inhibitors
  • src-Family Kinases / deficiency
  • src-Family Kinases / metabolism*

Substances

  • Acetylcysteine
  • Enzyme Inhibitors
  • Granulocyte Colony-Stimulating Factor
  • NADPH Oxidases
  • Phosphatidylinositol 3-Kinases
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphoproteins
  • Proto-Oncogene Proteins c-akt
  • Reactive Oxygen Species
  • Receptors, Granulocyte Colony-Stimulating Factor
  • src-Family Kinases
  • neutrophil cytosolic factor 1
  • lyn protein-tyrosine kinase